Commission aims to bring back medicine production to Europe

By |april 22nd, 2020|coronavirus, COVID-19, export bans, medicine imports, medicines, News, pharmaceutical strategy, Stella Kyriakides|

The EU needs to focus on ways to bring the production of medicines and pharmaceutical ingredients back to Europe to avoid a future recurrence of shortages experienced during the COVID-19 crisis, the EU health boss Stella Kyriakides told MEPs on Tuesday...

Komentarji so izklopljeni za Commission aims to bring back medicine production to Europe

Panic buying, trade curbs cause shortages of coronavirus drugs in EU

By |april 7th, 2020|coronavirus, medicines, News|

Hospitals in the European Union are facing shortages of critical drugs to treat COVID-19 patients because of trade restrictions and excessive stockpiling by EU governments, EU and industry officials said on Monday (6 April).

Komentarji so izklopljeni za Panic buying, trade curbs cause shortages of coronavirus drugs in EU

Katainen: Same level of priority for food and medicine in no-deal Brexit

By |april 5th, 2019|Brexit, Food safety, foodstuffs, Jyrki Katainen, medicines, medicines supply, News|

Medicine supplies and food safety standards are both vital and the EU cannot prioritise one over the other in the event of a no-deal Brexit, Vice President of the Commission Jyrki Katainen said on Thursday (4 April).

Komentarji so izklopljeni za Katainen: Same level of priority for food and medicine in no-deal Brexit

Flurry of agreements to cushion blow of no-deal Brexit

By |februar 27th, 2019|air transport, Brexit, customs, Hard Brexit, medicines, News, railways, road transport|

As Britain tries to steer away from a dreaded "no-deal" divorce with the EU, a flurry of agreements are being hammered out to cushion the most painful blows.

Komentarji so izklopljeni za Flurry of agreements to cushion blow of no-deal Brexit

Heavy workload delays EU report on environmental impact of drugs

By |junij 19th, 2018|Antimicrobial resistance, drugs, medicines, News|

The European Commission’s much-awaited communication on the environmental impact of pharmaceuticals is at an “advanced stage” but might not be adopted in the near future because of other legislative initiatives on the agenda, an EU official has told EURACTIV.com.

Komentarji so izklopljeni za Heavy workload delays EU report on environmental impact of drugs

Athens brings its dispute with pharma industry to the EU Council

By |november 24th, 2017|drug pricing, drug trade, drugs, medicines, News|

The next EU Health Council on 8 December will discuss the “lack of drug availability in Greece”, amid mounting tensions between the leftist government in Athens and the pharmaceutical companies.

Komentarji so izklopljeni za Athens brings its dispute with pharma industry to the EU Council

Pharmaceutical company gives free access to drug after clash with Greek government

By |november 2nd, 2017|drug pricing, drugs, medicines, News|

Following a clash with the Greek government over its decision to withdraw a cancer drug from the market, ROCHE, a Swiss multinational company, ultimately decided to make the drug available to patients for free.

Komentarji so izklopljeni za Pharmaceutical company gives free access to drug after clash with Greek government

Pharmaceutical company withdraws oncology drug from Greek market

By |oktober 30th, 2017|drug pricing, medicines, News|

A multinational pharmaceutical company has decided to withdraw an innovative oncology medicine from the Greek market, claiming that its price has fallen more than 50% because of the government’s regulatory interventions in the pharma area, EURACTIV.com has learnt.

Komentarji so izklopljeni za Pharmaceutical company withdraws oncology drug from Greek market

Protecting innovation in the pharmaceuticals market

By |oktober 10th, 2017|drugs, medicines, News, pharmaceuticals|

Hit hard by austerity, the health systems of EU member states are under huge pressure. Combined with an aging population and the alarming burden of chronic illnesses, EU member states have targeted specific aspects of the incentives granted to the phar...

Komentarji so izklopljeni za Protecting innovation in the pharmaceuticals market

Andriukaitis: Supporting drug innovation is ‘the only way’

By |oktober 10th, 2017|drugs, European Health Forum Gastein, generic drugs, intellectual property rights, medicines, News, Vytenis Andriukaitis|

Backing innovation in the pharmaceutical market and developing new evidence-based economic models is the only way forward for future healthcare, according to EU Commissioner for Health and Food Safety Vytenis Andriukaitis.

Komentarji so izklopljeni za Andriukaitis: Supporting drug innovation is ‘the only way’